Health Insurance and Efficiency

Health insurance does two jobs that can pull in opposite directions. It protects households from medical bills that would otherwise be difficult or impossible to absorb, but it also changes how health care is paid for and therefore changes the incentives facing patients, insurers and providers. Judging whether a health insurance arrangement is efficient requires looking at both sides of that bargain rather than asking only whether insured people spend more or less on care.

That distinction matters because lower spending is not automatically better, and higher spending is not automatically wasteful. A plan that discourages a patient from filling an effective prescription may reduce claims while making the overall result worse. A plan that pays for an expensive treatment can still be efficient if the treatment materially improves health and protects the patient from a financially devastating bill. The useful question is whether the insurance arrangement produces enough health and financial protection for the resources it consumes.

What efficiency means in health insurance

The efficiency of health care insurance is not a single measurement. One part is financial efficiency: how effectively premiums and public funding are converted into covered care and protection against large losses. Another is allocative efficiency: whether money and medical resources are being directed toward care that produces meaningful benefit. A third is administrative efficiency, which concerns the cost and complexity of enrolling people, processing claims, negotiating contracts, policing fraud, managing networks and deciding what the plan will cover.

Insurance also has value that does not show up as a medical service. A household can pay premiums for years without a major claim and still receive something economically useful because the policy limits exposure to uncertain losses. That risk transfer is the central reason insurance exists. It would therefore be misleading to call a plan inefficient merely because the average policyholder pays more in premiums than the insurer eventually pays for that individual. Premiums must fund the claims of people who do become sick, as well as administration and, in the case of many private insurers, a margin or surplus.

The scale of the health sector makes these distinctions consequential. U.S. national health expenditures reached $5.3 trillion in 2024, equal to $15,474 per person and 18.0% of gross domestic product. Private health insurance accounted for $1.645 trillion of that spending, while Medicare, Medicaid, out-of-pocket payments and other sources financed the rest.^[1] Those figures show how much is being spent, but they do not tell us by themselves whether the spending is efficient. The answer depends on prices, quantity and intensity of services, health outcomes, financial protection and the administrative resources required to make the system work.

Risk pooling adds another reason to resist an overly simple cost test. Medical needs are unevenly distributed and difficult to predict at the individual level. A functioning insurance pool deliberately transfers money from people who have few claims in a given period to people who have large claims. From the viewpoint of the person who remains healthy, that can look like a poor cash return. From the viewpoint of insurance economics, the ability to make a large uncertain loss manageable is part of the product being purchased.

How insurance changes the demand for care

Health insurance changes the price a patient faces at the point of care. If a service costs a provider or insurer $1,000 but the patient pays only a $30 copayment, the patient’s immediate decision is influenced far more by the $30 than by the full resource cost. Economists often describe the resulting increase in utilization as moral hazard. The term can sound accusatory, but in this context it does not require dishonesty or reckless behavior. It describes the predictable response to having part of the cost paid by someone else.

The response is real, but it should not be confused with a claim that insured people simply consume unnecessary care. Health care is unusual because patients often lack the information needed to judge which tests, drugs or procedures are appropriate, physicians strongly influence utilization, and serious illness can make shopping or delaying treatment unrealistic. Insurance also allows people to obtain beneficial care that they would have skipped because they could not afford the full price. The effect of coverage on the demand for health care therefore includes both additional low-value use and additional high-value use.

The RAND Health Insurance Experiment remains important because it randomly assigned families to plans with different levels of cost sharing. Participants who paid more of the cost used fewer services and spent less overall, but the reduction was not neatly targeted at waste. Cost sharing reduced the use of effective and less-effective services at roughly similar rates, and the main adverse health effects were concentrated among the sickest and poorest participants.^[2] The lesson is not that cost sharing fails. It is that changing the patient’s price is a blunt instrument when the patient’s ability to identify low-value care is limited.

Insurance can also improve efficiency by making care possible at an earlier or more appropriate time. A person who can afford a primary-care visit, diagnostic test or medication may avoid a more serious deterioration that is both medically harmful and expensive to treat. The difficult part is that the savings are not automatic. Some earlier care prevents larger future costs, some improves health while adding to total spending, and some produces little benefit. Good plan design tries to make those categories easier to distinguish rather than treating every extra dollar of utilization as equally desirable or equally wasteful.

This is why simply comparing an insured population with an uninsured population can lead to poor conclusions. Uninsured people often use less care because of financial barriers, but lower utilization created by inability to pay is not the same thing as efficient utilization. A useful efficiency test has to ask what care was forgone, what health benefit was lost, what financial risk was avoided and whether a different insurance design could have produced a better combination of access and cost.

Prices, bargaining power and provider networks

Insurance affects health spending through prices as well as through utilization. An insurer does not normally pay a hospital’s or physician’s list price for covered in-network care. It negotiates allowed amounts, builds provider networks and uses the promise of patient volume as part of its bargaining position. A strong insurer can sometimes obtain lower prices than an individual patient could negotiate alone, which means insurance can reduce the unit price of care even while coverage increases the number of services people use.

The bargaining result depends on market power on both sides. A hospital system that dominates a local market may be difficult for an insurer to exclude from its network, especially if employers and patients expect that hospital to be included. The Congressional Budget Office has found that provider market power is a major factor behind high commercial prices in the United States and that commercial insurers have generally paid substantially more than Medicare for hospital and physician services.^[3] The old idea that insurers necessarily force prices down simply because they buy in bulk is therefore incomplete. Bargaining power matters, and it can reside with the provider as well as the payer.

These price differences also complicate broad comparisons between a public system and private health care. Public programs often use administratively set payment rates or bargaining structures that differ from commercial insurance, while private plans may offer broader networks, different access arrangements or different payment incentives. A lower payment rate reduces spending per service, but if it becomes too low to sustain adequate provider participation it can create access problems. A higher payment rate may support capacity or quality in some circumstances, but it can also reflect market power rather than better care.

Provider networks are one way private insurers try to strengthen their position. Excluding a high-priced hospital can lower claims costs if patients have credible alternatives, and steering members toward lower-cost providers can make a plan more efficient without asking the patient to forgo care. Narrow networks have a cost of their own, however. They reduce choice, can disrupt established physician relationships and may impose travel or scheduling burdens. The relevant question is whether the savings come from buying comparable care at a better price or from making useful care harder to obtain.

Medical costs are also shaped by factors that an insurer cannot simply negotiate away. Labor, facilities, drugs, medical devices and new technologies all require resources, and some expensive care is expensive because it is genuinely resource-intensive. Efficiency analysis should therefore separate the price of a service from the clinical value of the service. A low-priced unnecessary test can still be wasteful, while a high-priced treatment that substantially extends or improves life can represent good value.

Cost sharing and the limits of consumer discipline

Deductibles, copayments and coinsurance give patients a reason to consider cost before using care. That can counter the tendency to consume more when insurance pays most of the bill, and it can reduce premiums by shifting some spending back to the enrollee. Cost sharing also preserves insurance for larger losses because the plan can concentrate more of its claims dollars on expenses that exceed the deductible or other patient contribution.

The trade-off becomes harder when cost sharing is high relative to a household’s available cash. A deductible that looks manageable on paper may still cause a person to delay a specialist visit, skip a diagnostic test or ration medication. If the forgone service was low value, spending falls with little loss. If it was clinically important, the plan has saved money by creating an access barrier rather than by eliminating waste. The same deductible can therefore produce very different efficiency results for a healthy high-income enrollee and for a lower-income person managing a chronic condition.

A more refined design tries to make the patient’s out-of-pocket price reflect the expected value of care rather than applying the same financial friction everywhere. Plans can charge little or nothing for services that are particularly valuable for a defined group, while using stronger incentives where substitution is easier or value is uncertain. This idea is often called value-based insurance design. It does not eliminate the need for judgment, because the value of a service can vary by diagnosis, age, risk level and available alternatives, but it is more targeted than assuming every dollar of medical spending should face the same deductible.

There is also a practical limit to consumer shopping. Patients can compare prices more effectively for scheduled, standardized services than for emergencies or complex episodes involving several providers. Even for planned care, the relevant price may be difficult to interpret because the patient’s final liability depends on negotiated rates, deductible status, coinsurance, network rules and how several services are billed. Efficiency gains from consumer price sensitivity are therefore more plausible where the service is shoppable and the patient has usable alternatives.

For an individual choosing a plan, a higher deductible should not be treated as automatically more efficient. The right comparison is the premium savings against the additional financial exposure, expected use of care, employer contributions, network quality and the risk that higher out-of-pocket costs will cause useful care to be postponed. A plan can be inexpensive in a healthy year and poor value in a year when substantial treatment is needed.

Administrative costs, care management and complexity

Health insurance requires administration because somebody has to define benefits, collect premiums, enroll members, contract with providers, process claims and resolve disputes. Private plans also market products and manage broker or employer relationships, while public programs have eligibility and payment systems of their own. Those activities consume money that could otherwise finance medical care, so administrative cost is a legitimate part of any efficiency assessment.

Not every administrative dollar is waste. Claims review can catch errors or fraud, network contracting can reduce prices, and utilization management can discourage services that are unlikely to help. Care-management programs can coordinate treatment for people with complex conditions, where fragmented care might otherwise lead to duplicated tests, conflicting medications or avoidable hospital use. The administrative function becomes inefficient when its cost and burden exceed the savings or clinical value it creates.

Prior authorization illustrates the tension. Requiring approval before an expensive service can prevent inappropriate use and give the insurer leverage to steer care toward an effective alternative. The same process can also impose paperwork on clinicians, delay treatment and create costs for patients and providers that do not appear in the insurer’s claims total. A plan that reports lower medical spending after transferring a large administrative burden elsewhere has not necessarily improved system-wide efficiency.

Complexity can also weaken the incentives that cost sharing is supposed to create. If patients cannot determine the likely price before receiving care, they cannot respond intelligently to that price. If clinicians spend substantial time navigating multiple formularies, networks and authorization rules, resources are being used to manage payment rather than deliver care. Simplification has value, although removing every control could allow prices or utilization to rise. The goal is not zero administration but administration that earns its cost.

Measuring value rather than simply spending less

An efficient health insurance arrangement should be judged against several outcomes at once: the health produced by covered care, the financial risk removed from households, the prices paid for services, the amount of low-value care avoided and the administrative resources used to operate the plan. None of those measures is sufficient by itself. A plan with low claims may be underinsuring its members, while a plan with generous coverage may be paying too much for providers or encouraging care that contributes little to health.

Prevention is a good example of why spending and value should not be confused. Vaccinations, screening and chronic-disease management can improve health and sometimes avoid costly future treatment, but preventive care does not need to save more money than it costs to be worthwhile. Some preventive services add net spending while producing health benefits that justify the expense. The efficiency question is whether the improvement is worth the resources used, not whether every preventive dollar returns more than a dollar in future medical savings.

Quality has to be handled the same way. Paying more for a provider can be justified when the higher payment buys materially better outcomes, safer care or reliable access that would otherwise be unavailable. Paying more because a dominant provider can demand a higher negotiated rate is different. Likewise, reducing utilization is beneficial when unnecessary services disappear, but harmful when patients abandon effective treatment because their share of the bill is unaffordable.

For households, efficiency ultimately becomes a plan-selection problem under uncertainty. Premiums are certain, but medical needs are not. Deductibles and coinsurance determine how much of that uncertainty remains with the household, while networks and coverage rules determine which services and providers the insurer will finance. A plan with a higher premium can be efficient for someone who needs expensive ongoing care or values broader access, just as a lower-premium plan with greater cost sharing can be efficient for someone who can comfortably absorb the risk and is unlikely to forgo necessary treatment.

At the system level, health insurance works best when it protects against financially serious medical risk without making the price and value of care irrelevant. That requires more than shifting costs to patients. Insurers and public payers also need incentives to negotiate effectively, contract with efficient providers, design benefits around clinical value and remove administrative steps that cost more than they save. Efficiency in health insurance is therefore not a choice between insurance and no insurance. It is the continuing task of getting more health and more financial protection from the money already flowing through the system.